Results 61 to 70 of about 412,112 (380)

Lung transplantation with concomitant cardiac repair for congenital hypoplasia of bilateral pulmonary arteries and patent ductus arteriosus

open access: yesJournal of Cardiothoracic Surgery, 2022
Background Profound pulmonary arterial hypertension with end-stage right heart failure is considered to be the main cause of death in children with un-repaired congenital heart disease, and the traditional surgical treatment is heart–lung transplantation.
Che-Chih Cheng   +3 more
doaj   +1 more source

Thoracic duct drainage in organ transplantation: Will it permit better immunosuppression? [PDF]

open access: yes, 1979
It is possible that thoracic-duct drainage, a major but neglected immunosuppressive adjunct, can have an important impact on organ transplantation.
Franks, JJ   +4 more
core  

Synthetic Bilirubin‐Based Nanomedicine Protects Against Renal Ischemia/Reperfusion Injury Through Antioxidant and Immune‐Modulating Activity

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
BX‐001N, a polyethylene glycol‐conjugated bilirubin 3α nanoparticle, is the first GMP‐grade, synthetic bilirubin‐based nanomedicine. It effectively attenuates acute renal injury, facilitates subacute renal recovery, and suppresses chronic fibrosis after renal ischemia/reperfusion injury via anti‐oxidant and immune‐modulating activity.
Ji‐Jing Yan   +13 more
wiley   +1 more source

Setting the ball rolling on post-transplant cardiac rehabilitation in India

open access: yesIHJ Cardiovascular Case Reports, 2022
Post-transplant cardiac rehabilitation reduces major adverse cardiac events and improves long-term survival but is nonexistent in India. This case series shows that cardiac rehabilitation improves health-related behaviour, health-related quality of life ...
Priya Chockalingam   +4 more
doaj  

Levosimendan in lung transplant recipients on VA‑ECMO

open access: yesВестник трансплантологии и искусственных органов, 2020
Chronic heart failure is one of the most dreadful complications in the early postoperative period following lung transplantation. At the same time, the effect of using levosimendan in the early post-lung transplant period is currently insignificant and ...
S. V. Zhuravel   +4 more
doaj   +1 more source

Engineered MSC Aggregates with E/N‐Cadherin and IL‐6 Preconditioning for the Treatment of Systemic Sclerosis

open access: yesAdvanced Healthcare Materials, EarlyView.
Engineered 3D‐Cad/IL6‐MSC, developed through synergistic hE/N‐cad‐Fc and IL‐6 preconditioning, show remarkable therapeutic potential for systemic sclerosis. These engineered MSC aggregates reduce pathogenic inflammatory cell infiltration and restore immune balance among CD4+ T‐cell populations, offering a promising approach to optimize MSC based ...
Yue Zhang   +11 more
wiley   +1 more source

Unusual right ventricle outflow tract obstruction in Dacron valved conduits

open access: yesInternational Journal of Cardiology Congenital Heart Disease, 2021
Various biological valved conduits have been used to treat the obstructions of the right ventricle. These conduits have different rates and etiologies for conduit stenosis during early- and long-term follow-up.
Mario Giordano   +3 more
doaj  

Successful Heart-Lung Transplantation in Saudi Arabia: A Case Report [PDF]

open access: yes, 2018
Heart-lung transplantation is a rare surgical option performed to replace both the heart and lungs in a single operation when other treatment options have failed.
Alrabah, Yazeed   +5 more
core   +1 more source

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival. [PDF]

open access: yes, 2019
Standard methods for detecting chronic lung allograft dysfunction (CLAD) and rejection have poor sensitivity and specificity and have conventionally required bronchoscopies and biopsies.
Damm, Izabella   +11 more
core   +2 more sources

Materials Advances in Devices for Heart Disease Interventions

open access: yesAdvanced Materials, EarlyView.
This review examines the crucial role of materials in heart disease interventions, focusing on strategies for monitoring, managing, and repairing heart conditions. It discusses the material requirements for medical devices, highlighting recent innovations and their impact on cardiovascular health.
Gagan K. Jalandhra   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy